Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hanne Verschuere"'
Autor:
Sofie Martens, Nozomi Takahashi, Gillian Blancke, Niels Vandamme, Hanne Verschuere, Tatyana Divert, Marnik Vuylsteke, Geert Berx, Peter Vandenabeele
Publikováno v:
Cell Death and Disease, Vol 13, Iss 4, Pp 1-10 (2022)
Abstract Cancers acquire several capabilities to survive the multistep process in carcinogenesis. Resisting cell death is one of them. Silencing of the necroptosis initiator Ripk3 occurs in a wide variety of cancer types including melanoma. Little is
Externí odkaz:
https://doaj.org/article/77587f1f6b4b4d57a3677719136c1aaf
Autor:
Caroline Merckx, Jana Zschüntzsch, Stefanie Meyer, Robrecht Raedt, Hanne Verschuere, Jens Schmidt, Boel De Paepe, Jan L. De Bleecker
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 17; Pages: 9567
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Duchenne Muscular Dystrophy (DMD) is a debilitating muscle disorder that condemns patients to year-long dependency on glucocorticoids. Chronic glucocorticoid use elicits many unfavourable side-effects without offering satisfying clinical improvement,
Autor:
Mathieu J.M. Bertrand, Iris Delrue, Liesbeth Heyndrickx, Wim Declercq, Tinneke Delvaeye, Dmitri V. Krysko, Sandy Adjemian, Agnieszka Kaczmarek, Joachim Taminau, Bram De Craene, Peter Vandenabeele, Tania Løve Aaes, Hanne Verschuere, Bartosz Wiernicki, Geert Berx
Publikováno v:
The Journal of Immunology
Immunogenic cell death (ICD) occurs when a dying cell releases cytokines and damage-associated molecular patterns, acting as adjuvants, and expresses Ags that induce a specific antitumor immune response. ICD is studied mainly in the context of regula
Autor:
Sofie Martens, Nozomi Takahashi, Gillian Blancke, Niels Vandamme, Hanne Verschuere, Tatyana Divert, Marnik Vuylsteke, Geert Berx, Peter Vandenabeele
Publikováno v:
CELL DEATH & DISEASE
Cancers acquire several capabilities to survive the multistep process in carcinogenesis. Resisting cell death is one of them. Silencing of the necroptosis initiator Ripk3 occurs in a wide variety of cancer types including melanoma. Little is known ab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a9f7cb184157242fe7a8f271150aacc
https://biblio.ugent.be/publication/8751984/file/8751989
https://biblio.ugent.be/publication/8751984/file/8751989
Autor:
Sofie, Martens, Nozomi, Takahashi, Gillian, Blancke, Niels, Vandamme, Hanne, Verschuere, Tatyana, Divert, Marnik, Vuylsteke, Geert, Berx, Peter, Vandenabeele
Publikováno v:
Cell deathdisease. 13(4)
Cancers acquire several capabilities to survive the multistep process in carcinogenesis. Resisting cell death is one of them. Silencing of the necroptosis initiator Ripk3 occurs in a wide variety of cancer types including melanoma. Little is known ab